• Politics
  • Economy
  • Stock
  • World News
  • Editor’s Pick
Investments Aims
Politics

Tariffs and Short-Term Pain: Why Thousands Are Stockpiling Medications

by April 10, 2025
by April 10, 2025

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)

President Trump understands that our reliance on foreign countries to supply us with critical prescription medications is an unacceptable national security threat – which is why his administration is taking aim at the industry. President Trump intends to use tariffs to bring the production of critical prescription medications BACK to the United States.

It’s a bold and absolutely necessary move to protect our fragile healthcare system. But it isn’t going to be painless. In the short term, it could mean skyrocketing prices, delayed access, and empty store shelves.

Trump’s new tariffs are hitting imports hard and while pharmaceuticals were given a brief exemption, the White House was clear: the industry is on notice. Drug companies that don’t move operations back to the U.S. will, as Trump says, “have a big tax to pay.”

Translation? Sooner or later, the cost of your medications is going up.

Industry analysts estimate a potential $45 billion spike in import costs to the pharma industry. And we’re already seeing it play out. Many of our partner pharmacies report rising costs, tighter supply, and longer lead times — especially for generics and essentials like antibiotics.

Most of the media attention has been on Wall Street’s reaction to the Trump tariffs. The reality is that the drop in the stock market is a natural – albeit jarring – response to the tariffs. Savvy investors know that these temporary dips in the markets are just that – temporary.

Riding out stock market instability is one thing, when it comes to access to prescription medications, however, that is an entirely different situation.

That’s why thousands of Americans are taking action today — stocking up on critical medical supplies before prices rise and products disappear from pharmacy shelves.

At The Wellness Company, they’re actively bolstering inventory to meet the needs of customers. But demand is spiking fast. If you want to protect your access to critical medications, now is the time to act.

Start with the best-sellers:

✅ The Medical Emergency Kit – 8 prescription medications, including ivermectin and five essential antibiotics that treat over 30 common illnesses. 

 ✅ The Contagion Emergency Kit – Developed using protocols from frontline experts like Dr. Peter McCullough, this kit includes:

  • Ivermectin

  • Hydroxychloroquine

  • Azithromycin (Z-Pak)

  • Oseltamivir (Tamiflu)

  • Budesonide (with a free nebulizer)

And here’s the good news:

If you order now, they will honor ALL EXISTING PRICES, regardless of our rising costs. They’re doing this because we believe in putting people over profits — especially in times like these.

This includes replenishment costs for up to three medications from a previously purchased emergency kit for a full two years after purchase. That’s long-term peace of mind.

The world may be unpredictable. But your access to life-saving medications shouldn’t be.

Stock up now and breathe easier tomorrow.

Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.

The post Tariffs and Short-Term Pain: Why Thousands Are Stockpiling Medications appeared first on The Gateway Pundit.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Chinese Yuan Falls to Lowest Level Since 2007 After Trump Tariffs Kicked In
next post
O’Keefe Releases Covert Recording of Florida Tech President Admitting to ‘Tweaking the Language’ of DEI Courses to Bypass DEI Ban and Secure Millions in Taxpayer Funding (VIDEO)

You may also like

REPORT: Israeli Officials “Shocked” over Trump’s Houthi Truce...

May 9, 2025

A Conservative Catholic Resurgence Meets a Moderate Pope

May 9, 2025

Update: Trump Greenlights Resettlement of White South Africans...

May 9, 2025

Christian Actor Neal McDonough Says “Beacon of Light”...

May 9, 2025

Unhinged Rapper Kanye West Sparks Outrage After Release...

May 9, 2025

Globalist Billionaire Bill Gates Vows to Give Away...

May 9, 2025

BREAKING: Former Supreme Court Justice David Souter Dead...

May 9, 2025

DNI Gabbard Reveals 11 Active Investigations Into Intel...

May 9, 2025

MUST SEE: Male Heckler Hits Letitia James With...

May 9, 2025

WATCH: Race Baiting Democrat Jasmine Crockett Attacks Republicans...

May 9, 2025

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • REPORT: Israeli Officials “Shocked” over Trump’s Houthi Truce – Trump Reportedly Upset with Netanyahu for Trying to Get U.S. involved in Military Conflict with Iran Ahead of Nuclear Talks and Visit to Middle East

    May 9, 2025
  • A Conservative Catholic Resurgence Meets a Moderate Pope

    May 9, 2025
  • Update: Trump Greenlights Resettlement of White South Africans Amid Rampant Racial Persecution

    May 9, 2025
  • Christian Actor Neal McDonough Says “Beacon of Light” Gold Company Can Be Trusted in These Crazy Times

    May 9, 2025
  • Unhinged Rapper Kanye West Sparks Outrage After Release of Bizarre “Heil Hitler” Music Video on Victory in Europe Day

    May 9, 2025
  • Terms & Conditions
  • Privacy Policy
  • Contact us
  • About us

Copyright © 2024 Investments Aims. All Rights Reserved.

Investments Aims
  • Politics
  • Economy
  • Stock
  • World News
  • Editor’s Pick